Orchestra BioMed Holdings, Inc.

OBIO · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$21-$19-$19-$16
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$3$3$3
Change in WC$3$0-$1-$1
Other Non-Cash$4$0$0$1
Operating Cash Flow-$15-$16-$17-$14
Investing Activities
PP&E Inv.-$0-$0-$0-$0
Net Acquisitions$0$0$0-$1
Inv. Purchases-$48$0-$3-$20
Inv. Sales/Matur.$10$16$16$17
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$39$16$13-$4
Financing Activities
Debt Repay.$19$0$0$15
Stock Issued$58$0$0$0
Stock Repurch.$0-$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0$0-$0-$1
Financing Cash Flow$76-$0-$0$14
Forex Effect$0$0$0$0
Net Chg. in Cash$23$0-$4-$3
Supplemental Information
Beg. Cash$19$18$22$26
End Cash$42$19$18$22
Free Cash Flow-$15-$16-$17-$14
Orchestra BioMed Holdings, Inc. (OBIO) Financial Statements & Key Stats | AlphaPilot